Representative before the EPO

Employment test 51 - 200 employees
Company dna potter clarkson llp
operating since 1889
Headquarter in Nottingham and 1 office
active in Legal Services, IP Consulting, and IP Portfolio Processing

We have observed 11 EP applications Ian Edward Stevens has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after January 22, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12700765

COMBINATION THERAPY OF HSP90 INHIBITORY COMPOUNDS WITH PROTEASOME INHIBITORS

IPC classification:
A61K 31/4196, A61K 31/5377, A61K 31/675, A61K 45/06, A61P 35/00
Applicant:
Synta Pharmaceuticals Corp.
Agent:
Ian Edward Stevens, Potter Clarkson LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11859661

UP-CONVERSION DEVICES WITH A BROAD BAND ABSORBER

IPC classification:
H01L 31/10, H01L 33/02
Applicant:
University of Florida Research Foundation
Agent:
Ian Edward Stevens, Potter Clarkson LLP
Status:
GRANT OF PATENT INTENDED
EP11859925

INFRARED PASS VISIBLE BLOCKER FOR UPCONVERSION DEVICES

IPC classification:
G01J 1/02, H01L 31/09
Applicant:
University of Florida Research Foundation
Agent:
Ian Edward Stevens, Potter Clarkson LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12722587

METHOD AND DEVICE FOR REMOVING PARTICLES FROM LIQUID AND PLACING THEM INTO A HOLDING DEVICE

IPC classification:
B01L 3/02, G01N 35/10
Agent:
Ian Edward Stevens, Potter Clarkson LLP
Status:
APPLICATION WITHDRAWN
EP12724523

COMBINATION THERAPY OF HSP90 INHIBITORY COMPOUNDS WITH CHK INHIBITORS

IPC classification:
A61K 31/405, A61K 31/4196, A61K 31/4535, A61K 31/497, A61K 31/506, A61K 31/519, A61K 31/551, A61P 35/00
Applicant:
Synta Pharmaceuticals Corp.
Agent:
Ian Edward Stevens, Potter Clarkson LLP
Status:
GRANT OF PATENT INTENDED
EP12724504

COMBINATION THERAPY OF HSP90 INHIBITORY COMPOUNDS WITH MEK INHIBITORS

IPC classification:
A61K 31/166, A61K 31/277, A61K 31/352, A61K 31/416, A61K 31/4196, A61K 31/675, A61K 35/00, A61K 45/06
Applicant:
Synta Pharmaceuticals Corp.
Agent:
Ian Edward Stevens, Potter Clarkson LLP
Status:
GRANT OF PATENT INTENDED
EP12723814

COMBINATION THERAPY OF HSP90 INHIBITORY COMPOUNDS WITH MTOR/PI3K INHIBITORS

IPC classification:
A61K 31/4196, A61K 31/675, A61K 45/06, A61P 35/00
Applicant:
Synta Pharmaceuticals Corp.
Agent:
Ian Edward Stevens, Potter Clarkson LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12825553

PHOTODETECTOR AND UPCONVERSION DEVICE WITH GAIN (EC)

IPC classification:
H01L 31/101
Applicant:
University of Florida Research Foundation
Agent:
Ian Edward Stevens, Potter Clarkson LLP
Status:
EXAMINATION REQUESTED
EP12789725

EXPANDABLE DEVICE FOR TISSUE COLLECTION FROM AN AERODIGESTIVE BODY LUMEN

IPC classification:
A61B 10/02, A61B 10/04, A61B 17/3207
Agent:
Ian Edward Stevens, Potter Clarkson LLP
Status:
EXAMINATION IN PROGRESS
EP13275192

Fat composition

IPC classification:
A23D 9/00, A23D 9/02, C11B 7/00, C11C 3/10
Agent:
Ian Edward Stevens, Potter Clarkson LLP
Status:
EXAMINATION IN PROGRESS
EP13275202

Fat composition for improved body fat distribution

IPC classification:
A23D 9/00, A23D 9/02, A23L 1/29, A61K 31/215, A61P 3/04
Agent:
Ian Edward Stevens, Potter Clarkson LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN

Please Sign in to use this feature